Dhaval Kolte
Cardiovascular Disease · Boston, MANPI 1003180431
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (37.9%), food and beverage and consulting fees — rather than concentrated in one kind of arrangement. 8 manufacturers reported payments, led by Edwards Lifesciences at 28.5% of the total.
Across 72 payments — averaging $155.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Edwards Lifesciences$3K
- Philips North America LLC$3K
- Medtronic$2K
- Boston Scientific$1K
- Abbott$412
- Penumbra, Inc.$365
- plus $456 from 2 others
What the payments were for
- Consulting fees$3,12828%
- Travel & lodging$4,24238%
- Food & beverage$3,80934%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Edwards Lifesciences | 12 | $3,185 |
| Philips North America LLC | 2 | $3,153 |
| Medtronic(2 entities) | 39 | $2,228 |
| Boston Scientific | 8 | $1,379 |
| Abbott | 4 | $412 |
| Penumbra, Inc. | 3 | $365 |
| Biotronik Inc. | 2 | $229 |
| Cardiovascular Systems Inc. | 2 | $227 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- (9547) IGT Systems Undivided$3,128
- PASCAL$2,621
- COREVALVE EVOLUT R$1,037
- XIENCE V$383
- CoreValve Evolut$321
- Indigo System$255
- Coronary Orbital Atherectomy System$227
- GENERAL - THERAPIES$170
- Edwards SAPIEN 3 Transcatheter Heart Valve$134
- Orsiro Mission$123
- Indigo$110
- PRO-Kinetic Energy$106
- Pulsar$106
- Astron; Pulsar; AstronPulsar$106
- PK Papyrus$106
- Orsiro$106
How this compares
$11,179 in reported general payments places this provider in the 75th percentile of 750 cardiovascular disease providers in Massachusetts.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other cardiovascular disease in Boston
- Marc SabatineBoston$3.9M
- Elizabeth NabelBoston$2.2M
- Kenneth RosenfieldBoston$1.4M
- James JanuzziBoston$1.1M
- Muthiah VaduganathanBoston$972K
- Joseph LoscalzoBoston$926K
- Sunil KapurBoston$823K
- Paul ZeiBoston$786K
- Paul RidkerBoston$572K
- Ignacio Inglessis-AzuajeBoston$545K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.